PMID- 27363720 OWN - NLM STAT- MEDLINE DCOM- 20170605 LR - 20181113 IS - 1474-9726 (Electronic) IS - 1474-9718 (Print) IS - 1474-9718 (Linking) VI - 15 IP - 5 DP - 2016 Oct TI - KCa 3.1 upregulation preserves endothelium-dependent vasorelaxation during aging and oxidative stress. PG - 801-10 LID - 10.1111/acel.12502 [doi] AB - Endothelial oxidative stress develops with aging and reactive oxygen species impair endothelium-dependent relaxation (EDR) by decreasing nitric oxide (NO) availability. Endothelial KCa 3.1, which contributes to EDR, is upregulated by H2 O2 . We investigated whether KCa 3.1 upregulation compensates for diminished EDR to NO during aging-related oxidative stress. Previous studies identified that the levels of ceramide synthase 5 (CerS5), sphingosine, and sphingosine 1-phosphate were increased in aged wild-type and CerS2 mice. In primary mouse aortic endothelial cells (MAECs) from aged wild-type and CerS2 null mice, superoxide dismutase (SOD) was upregulated, and catalase and glutathione peroxidase 1 (GPX1) were downregulated, when compared to MAECs from young and age-matched wild-type mice. Increased H2 O2 levels induced Fyn and extracellular signal-regulated kinases (ERKs) phosphorylation and KCa 3.1 upregulation. Catalase/GPX1 double knockout (catalase(-/-) /GPX1(-/-) ) upregulated KCa 3.1 in MAECs. NO production was decreased in aged wild-type, CerS2 null, and catalase(-/-) /GPX1(-/-) MAECs. However, KCa 3.1 activation-induced, N(G) -nitro-l-arginine-, and indomethacin-resistant EDR was increased without a change in acetylcholine-induced EDR in aortic rings from aged wild-type, CerS2 null, and catalase(-/-) /GPX1(-/-) mice. CerS5 transfection or exogenous application of sphingosine or sphingosine 1-phosphate induced similar changes in levels of the antioxidant enzymes and upregulated KCa 3.1. Our findings suggest that, during aging-related oxidative stress, SOD upregulation and downregulation of catalase and GPX1, which occur upon altering the sphingolipid composition or acyl chain length, generate H2 O2 and thereby upregulate KCa 3.1 expression and function via a H2 O2 /Fyn-mediated pathway. Altogether, enhanced KCa 3.1 activity may compensate for decreased NO signaling during vascular aging. CI - (c) 2016 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd. FAU - Choi, Shinkyu AU - Choi S AD - Department of Physiology, Medical School, Ewha Womans University, Seoul, South Korea. FAU - Kim, Ji Aee AU - Kim JA AD - Department of Physiology, Medical School, Ewha Womans University, Seoul, South Korea. FAU - Li, Hai-Yan AU - Li HY AD - Department of Physiology, Medical School, Ewha Womans University, Seoul, South Korea. FAU - Shin, Kyong-Oh AU - Shin KO AD - College of Pharmacy and MRC, Chungbuk National University, Chongju, South Korea. FAU - Oh, Goo Taeg AU - Oh GT AD - Department of Life Sciences, Ewha Womans University, Seoul, South Korea. FAU - Lee, Yong-Moon AU - Lee YM AD - College of Pharmacy and MRC, Chungbuk National University, Chongju, South Korea. FAU - Oh, Seikwan AU - Oh S AD - Department of Molecular Medicine, Medical School, Ewha Womans University, Seoul, South Korea. FAU - Pewzner-Jung, Yael AU - Pewzner-Jung Y AD - Department of Biological Chemistry, Weizmann Institute of Science, Rehovot, Israel. FAU - Futerman, Anthony H AU - Futerman AH AD - Department of Biological Chemistry, Weizmann Institute of Science, Rehovot, Israel. FAU - Suh, Suk Hyo AU - Suh SH AD - Department of Physiology, Medical School, Ewha Womans University, Seoul, South Korea. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20160630 PL - England TA - Aging Cell JT - Aging cell JID - 101130839 RN - 0 (Antioxidants) RN - 0 (Intermediate-Conductance Calcium-Activated Potassium Channels) RN - 0 (Kcnn4 protein, mouse) RN - 0 (Sphingolipids) RN - 2149-70-4 (Nitroarginine) RN - BBX060AN9V (Hydrogen Peroxide) RN - EC 1.- (Oxidoreductases) RN - EC 1.3.1.- (dihydroceramide desaturase) RN - EC 2.7.10.2 (Fyn protein, mouse) RN - EC 2.7.10.2 (Proto-Oncogene Proteins c-fyn) RN - EC 2.7.11.24 (Extracellular Signal-Regulated MAP Kinases) RN - XXE1CET956 (Indomethacin) SB - IM MH - Aging/drug effects/*physiology MH - Animals MH - Antioxidants/metabolism MH - Aorta/pathology MH - Endothelial Cells/metabolism/pathology MH - Endothelium, Vascular/drug effects/*physiology MH - Enzyme Activation/drug effects MH - Extracellular Signal-Regulated MAP Kinases/metabolism MH - Hydrogen Peroxide/metabolism MH - Indomethacin/pharmacology MH - Intermediate-Conductance Calcium-Activated Potassium Channels/*metabolism MH - Ion Channel Gating/drug effects MH - Mice, Knockout MH - Models, Biological MH - Nitroarginine/pharmacology MH - Oxidative Stress/*drug effects MH - Oxidoreductases/deficiency/metabolism MH - Proto-Oncogene Proteins c-fyn/metabolism MH - Sphingolipids/metabolism MH - *Up-Regulation/drug effects MH - *Vasodilation/drug effects PMC - PMC5013018 OTO - NOTNLM OT - Ca2+-activated K+ channel OT - aging OT - ceramide synthase 2 ablation OT - endothelial cells OT - oxidative stress OT - redox enzymes EDAT- 2016/07/02 06:00 MHDA- 2017/06/06 06:00 PMCR- 2016/10/01 CRDT- 2016/07/02 06:00 PHST- 2016/03/17 00:00 [accepted] PHST- 2016/07/02 06:00 [entrez] PHST- 2016/07/02 06:00 [pubmed] PHST- 2017/06/06 06:00 [medline] PHST- 2016/10/01 00:00 [pmc-release] AID - ACEL12502 [pii] AID - 10.1111/acel.12502 [doi] PST - ppublish SO - Aging Cell. 2016 Oct;15(5):801-10. doi: 10.1111/acel.12502. Epub 2016 Jun 30.